Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xin-Qi Teng"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ae9928dfba934173ac2f07bc6b064406
Publikováno v:
Experimental and Molecular Medicine, Vol 55, Iss 2, Pp 290-303 (2023)
Brain cancer: opportunities to block “super-enhanced” tumor growth “Superenhancer” regions within the genome help coordinate the malignant growth of brain tumors, and could offer a target for the development of therapies and prognostic biomar
Externí odkaz:
https://doaj.org/article/afbb23af39304956ad49d92908a8474f
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliom
Externí odkaz:
https://doaj.org/article/a038bcad0b464f7196ba7a73a1c822d0
Autor:
A-Xi Shi, Qiang Qu, Hai-Hui Zhuang, Xin-Qi Teng, Wei-Xin Xu, Yi-Ping Liu, Yi-Wen Xiao, Jian Qu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%–65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs
Externí odkaz:
https://doaj.org/article/bacc6267e4814c2896993920dfc02cbe
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Gliomas are central nervous system tumors originating from glial cells, whose incidence and mortality rise in coming years. The current treatment of gliomas is surgery combined with chemotherapy or radiotherapy. However, developing therapeutic resist
Externí odkaz:
https://doaj.org/article/5bc3e8ac77f745619cdbbce05d2a7238
Autor:
Xin-Qi Teng, Qiang Qu, Yue Luo, Wen-Ming Long, Hai-Hui Zhuang, Jiao-Hua Xu, Yu-Xin Wen, Hui-Lin Zhang, Jian Qu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aims: Carbapenem-resistant K. pneumoniae (CRKP) is the most common carbapenem-resistant Enterobacteriaceae with high mortality. Ceftazidime-avibactam (CAZ-AVI) has exhibited excellent in vitro activity in vivo against CRKP. However, the efficacy of C
Externí odkaz:
https://doaj.org/article/604d4378dde640f4aed9e4e2924818ae
Autor:
Guo-Hua Li, Qiang Qu, Ting-Ting Qi, Xin-Qi Teng, Hai-Hong Zhu, Jiao-Jiao Wang, Qiong Lu, Jian Qu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Abstract Although new developments of surgery, chemotherapy, radiotherapy, and immunotherapy treatments for cancer have improved patient survival, the emergence of chemoresistance in cancer has significant impacts on treatment effects. The developmen
Externí odkaz:
https://doaj.org/article/a04e59d514fe4b10b9addf8fdfe6a90b
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Polymyxin B (PMB), a kind of polymyxin, was widely used in carbapenem-resistant Gram-negative bacterial (CR-GNB) infections. However, adverse reactions such as nephrotoxicity and neurotoxicity limit its use in clinical practice. The aim of this study
Externí odkaz:
https://doaj.org/article/dd9a0c9babe4489da78a736b50e1149f
Autor:
Qiong Lu, Hai-Hong Zhu, Guo-Hua Li, Ting-Ting Qi, Liang-Jun Ye, Xin-Qi Teng, Qiang Qu, Ge-Fei He, Jian Qu
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Objective: The emergence of carbapenem-resistant gram-negative bacteria (CR-GNB) has brought great challenges to clinical anti-infection treatment around the world. Polymyxins are often considered as the last line of defense in the treatment of CR-GN
Externí odkaz:
https://doaj.org/article/2006245a98c34aaa87eb4e59f4b54619
Autor:
Wei-Xin Xu, Qiang Qu, Hai-Hui Zhuang, Xin-Qi Teng, Yi-Wen Wei, Jian Luo, Ying-Huan Dai, Jian Qu
Publikováno v:
International Journal of Biological Sciences; 2024, Vol. 20 Issue 5, p1652-1668, 17p